T. Rowe Price Associates’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
|
|||||
|
2025
Q1 | $740K | Buy |
|
|||||
|
2024
Q4 | $563K | Sell |
|
|||||
|
2024
Q3 | $819K | Buy |
|
|||||
|
2024
Q2 | $575K | Buy |
|
|||||
|
2024
Q1 | $499K | Sell |
|
|||||
|
2023
Q4 | $1.44M | Sell |
|
|||||
|
2023
Q3 | $1.68M | Sell |
|
|||||
|
2023
Q2 | $10.4M | Sell |
|
|||||
|
2023
Q1 | $15.5M | Sell |
|
|||||
|
2022
Q4 | $14M | Sell |
|
|||||
|
2022
Q3 | $13.5M | Sell |
|
|||||
|
2022
Q2 | $98.6M | Sell |
|
|||||
|
2022
Q1 | $172M | Sell |
|
|||||
|
2021
Q4 | $373M | Buy |
|
|||||
|
2021
Q3 | $389M | Buy |
|
|||||
|
2021
Q2 | $448M | Buy |
|
|||||
|
2021
Q1 | $387M | Buy |
|
|||||
|
2020
Q4 | $352M | Buy |
|
|||||
|
2020
Q3 | $187M | Buy |
|
|||||
|
2020
Q2 | $132M | Sell |
|
|||||
|
2020
Q1 | $91.8M | Buy |
|
|||||
|
2019
Q4 | $65.9M | Buy |
|
|||||
|
2019
Q3 | $21.8M | Sell |
|
|||||
|
2019
Q2 | $43.5M | Buy |
|